The Indian Bar Association (IBA), a voluntary organisation, say it has served a second legal notice to WHO Chief Scientist Soumya Swaminathan for allegedly “running a disinformation campaign against Ivermectin”, after WHO failed to recommend use of the anti-parasitic drug as a COVID-19 treatment – due to a lack of evidence of efficacy.
The Mumbai-based IBA sent a 51-page notice to Swaminathan on 25 May, and a follow-up on 13 June, reacting to her statements saying that WHO does not recommend the use of the drug as a treatment for COVID-19, except in the context of clinical trials.
A tweet by Swaminathan specifically advising against the use of Ivermectin for COVID-19, which the IBA has called “controversial”, has since been deleted.
The tweet, issued under Swaminathan’s handle, @doctorsoumya, on 10 May 2021 stated that “Safety and efficacy are important when using any drug for a new indication. @WHO recommends against the use of Ivermectin for #COVID19 except within clinical trials.”
The WHO has said there is, to date, insufficient evidence to demonstrate Ivermectin’s effectiveness against COVID-19, and has thus not included it as a recommended COVID treatment – except in clinical trial studies that might yield better evidence.
In her role as WHO’s Chief Scientist, Swaminathan has also spoken out against the use of politically popular, but scientifically unfounded, treatments, including hydroxychloroquine and Remdesivir – the latter of which even received United States Food and Drug Administration emergency use approval, despite what WHO said was a lack of evidence about efficacy.
The IBA, which Indian insiders say tends to parrot positions of the government of Prime Minister Narendra Modi, has attacked Swaminathan, a former senior Indian medical official, on a personal level, calling her statements “highly unconscionable, misleading and issued with ulterior purposes and deliberate intention to underplay the effectiveness of Ivermectin in treatment COVID-19.”
“The legal notice is just the first step. We are going to be taking it forward. There are forces working to repress Ivermectin for reasons mentioned in the notice,” said Dipali Ojha, the author of the notice and head of the IBA’s legal cell.
In a response, WHO said it “regretted” the unwarranted attacks against senior officials in the media,” adding that despite the publication of the alleged suit, it was unaware of any formal proceedings having been filed by the IBA. Of note, the group is a voluntary organisation with no statutory or regulatory status in India.
“WHO’s assessment of Ivermectin for treatment of COVID-19 is based on the current state of scientific evidence. WHO guidelines are developed by an independent global guidelines development group and are updated regularly when new data becomes available,” a spokesperson said.
Rest of article here.